Ansari, A <br/><br/>
Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Sep 2008 
 - 734-41 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2008.03782.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Allopurinol--therapeutic use<br/>Chemical and Drug Induced Liver Injury--drug therapy<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Drug Therapy, Combination<br/>Drug-Related Side Effects and Adverse Reactions--prevention & control<br/>Enzyme Inhibitors--therapeutic use<br/>Female<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Inflammatory Bowel Diseases--drug therapy<br/>Male<br/>Mercaptopurine--adverse effects<br/>Methyltransferases--metabolism<br/>Middle Aged<br/>Retrospective Studies<br/>Treatment Outcome